By Tokio X'press Vaccine, flu, medical service, Pharmaceutical
COVID-19: Chugai expands indications for antibody cocktail therapy: Lonapreve
Shionogi:Production of corona oral medicine: Approval application by the end of the year
COVID-19: Shionogi, final clinical trial with corona drug: S-217622
Will Favipiravir Make it to North America?
US FDA: Takeda Pharmaceutical’s Lung Cancer Treatment Approval: Exkivity